HUT77943A - 2,5-Dioxo-piperazin-származékok, eljárás előállításukra és alkalmazásuk, valamint közbenső termékei - Google Patents

2,5-Dioxo-piperazin-származékok, eljárás előállításukra és alkalmazásuk, valamint közbenső termékei Download PDF

Info

Publication number
HUT77943A
HUT77943A HU9800398A HU9800398A HUT77943A HU T77943 A HUT77943 A HU T77943A HU 9800398 A HU9800398 A HU 9800398A HU 9800398 A HU9800398 A HU 9800398A HU T77943 A HUT77943 A HU T77943A
Authority
HU
Hungary
Prior art keywords
methyl
compound
phenyl
ethyl
dimethoxy
Prior art date
Application number
HU9800398A
Other languages
English (en)
Hungarian (hu)
Inventor
Philip Anthony Ashworth
Stephen James Brocchini
Sukhjit Hunjan
Ian Andrew Pretswell
Hamish Ryder
Original Assignee
Xenova Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Limited filed Critical Xenova Limited
Publication of HUT77943A publication Critical patent/HUT77943A/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU9800398A 1994-12-23 1995-12-22 2,5-Dioxo-piperazin-származékok, eljárás előállításukra és alkalmazásuk, valamint közbenső termékei HUT77943A (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9426224.3A GB9426224D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
HUT77943A true HUT77943A (hu) 1998-12-28

Family

ID=10766589

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800398A HUT77943A (hu) 1994-12-23 1995-12-22 2,5-Dioxo-piperazin-származékok, eljárás előállításukra és alkalmazásuk, valamint közbenső termékei

Country Status (19)

Country Link
EP (1) EP0799222A1 (cs)
JP (1) JPH10511384A (cs)
CN (1) CN1175253A (cs)
AU (1) AU698828B2 (cs)
BG (1) BG101602A (cs)
BR (1) BR9510410A (cs)
CA (1) CA2207500A1 (cs)
CZ (1) CZ190097A3 (cs)
FI (1) FI972660A7 (cs)
GB (1) GB9426224D0 (cs)
HU (1) HUT77943A (cs)
IL (1) IL116525A0 (cs)
NO (1) NO972937L (cs)
NZ (1) NZ297847A (cs)
PL (1) PL320916A1 (cs)
SK (1) SK83697A3 (cs)
TW (1) TW358094B (cs)
WO (1) WO1996020190A1 (cs)
ZA (1) ZA9510909B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
CN100354265C (zh) * 1996-10-18 2007-12-12 埃克森诺瓦有限公司 邻氨基苯甲酸衍生物及其制备方法和作为多种抗性调节剂的用途
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
SK4782001A3 (en) 1998-10-08 2001-11-06 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
MXPA02006826A (es) * 2000-01-18 2004-04-05 Nereus Phamraceuticals Inc Un inhibidor de division celular y un metodo de produccion del mismo.
US7220414B2 (en) 2000-09-06 2007-05-22 A.P. Pharma, Inc. Degradable polyacetal polymers
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
ATE374767T1 (de) 2002-08-02 2007-10-15 Nereus Pharmaceuticals Inc Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
CA2978679A1 (en) 2015-03-06 2016-09-15 Beyondspring Pharmaceuticals, Inc. Method of treating a brain tumor
CA2978567A1 (en) 2015-03-06 2016-09-15 Beyondspring Pharmaceuticals, Inc. Method of treating cancer associated with a ras mutation using plinabulin
KR102680823B1 (ko) 2015-07-13 2024-07-03 비욘드스프링 파마수티컬스, 인코포레이티드. 플리나불린 조성물
BR112018016054A2 (pt) 2016-02-08 2019-02-12 Beyondspring Pharmaceuticals, Inc. composições farmacêuticas e/ou métodos para tratar câncer e/ou para romper vasculatura de tumor associada ao câncer em indivíduo
EP3463337A4 (en) 2016-06-06 2020-02-12 Beyondspring Pharmaceuticals, Inc. COMPOSITION AND METHOD FOR REDUCING NEUTROPENIA
EP3565812B1 (en) 2017-01-06 2023-12-27 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
EP3576733A4 (en) 2017-02-01 2020-11-25 Beyondspring Pharmaceuticals, Inc. NEUTROPENIA REDUCTION METHOD
WO2019147615A1 (en) 2018-01-24 2019-08-01 Beyondspring Pharmaceuticals, Inc. Composition and method for reducing thrombocytopenia via the administration of plinabulin
WO2022216908A1 (en) 2021-04-09 2022-10-13 Beyondspring Pharmaceuticals, Inc. Therapeutic compositions and methods for treating tumors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103479T3 (es) * 1992-07-10 1997-09-16 Glaxo Lab Sa Derivados de anilida.
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
PL320916A1 (en) 1997-11-10
SK83697A3 (en) 1998-05-06
AU698828B2 (en) 1998-11-05
FI972660L (fi) 1997-08-22
FI972660A7 (fi) 1997-08-22
CN1175253A (zh) 1998-03-04
FI972660A0 (fi) 1997-06-19
BG101602A (en) 1998-02-27
NZ297847A (en) 1999-04-29
CZ190097A3 (cs) 1998-01-14
WO1996020190A1 (en) 1996-07-04
AU4310096A (en) 1996-07-19
GB9426224D0 (en) 1995-02-22
NO972937D0 (no) 1997-06-23
BR9510410A (pt) 1999-09-08
ZA9510909B (en) 1996-08-30
IL116525A0 (en) 1996-03-31
TW358094B (en) 1999-05-11
JPH10511384A (ja) 1998-11-04
NO972937L (no) 1997-06-23
EP0799222A1 (en) 1997-10-08
CA2207500A1 (en) 1996-07-04

Similar Documents

Publication Publication Date Title
HUT77943A (hu) 2,5-Dioxo-piperazin-származékok, eljárás előállításukra és alkalmazásuk, valamint közbenső termékei
US6734203B2 (en) Fused imidazolium derivatives
JP6965360B2 (ja) o−アミノヘテロアリールアルキニル基含有化合物およびその製造方法と用途
KR100660309B1 (ko) 시아노페닐 유도체
CN114761003B (zh) 具有雄激素受体降解活性的新型脲类及其用途
KR20020093086A (ko) 축합 헤테로아릴 유도체
JP2010514689A (ja) 癌、炎症およびウイルス感染症の処置のためのcdk阻害剤としてのヘテロアリール−ヘテロアリール化合物
CN101333192A (zh) 作为钠通道阻滞剂的联芳基取代吡唑
JP2007509158A (ja) 肥満、糖尿病、うつ病及び不安を治療するためのmchr1アンタゴニストとしての3−(4−アミノフェニル)チエノピリミド−4−オン誘導体
EP2928466B1 (en) Use of maleimide derivatives for preventing and treating leukemia
JP2021500334A (ja) Ehmt2阻害剤としてのアミン置換複素環化合物、その塩、及びそれらの合成方法
AU700891B2 (en) Piperazine-2,5-dione derivatives as modulators of multidrug resistance
JP2004519486A (ja) クロマン誘導体、その製造方法及びその抗腫瘍剤としての使用
JPWO2005080322A1 (ja) フルオレン誘導体
JP2001328938A (ja) シアノフェニル誘導体を有効成分とする医薬
JP7494224B2 (ja) ビアリールジアルキルホスフィンオキシドfpr2アゴニスト
KR101035709B1 (ko) 신규2-치환아미노알킬레닐옥시-3-치환페닐에티닐-6-아미노퀴녹살린 유도체
JP2747013B2 (ja) ブテン酸又はプロペン酸誘導体
JP2003529532A (ja) 4−3−置換−アミノ−シクロブト−3−エン−1,2−ジオン及び平滑筋収縮に影響を及ぼすための使用
WO1998014430A1 (en) Pyrimidine derivatives
CN115850282A (zh) 靶向降解egfr蛋白的化合物及其制备方法和应用

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal